glp-1 이란 당뇨병 치료제] GLP1 receptor agonists(GLP-1 유사체) 알아보기 요즘 핫이슈인 GLP-1(Glucagon-like peptide-1)이란? :

Rare postmarketing reports of intestinal obstruction have also been noted

In 2025, Ozempic was approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease and kidney failure in people with type 2 diabetes

Similarly, those switching from Zepbound to orforglipron experienced a 2.6 kg gain versus a 9.1 kg gain for placebo

issues: This can include nausea, vomiting, stomach cramps, bloating, constipation, and diarrhea

It produces real clinical consequences that require proactive management

Additionally, another robust randomized controlled trial found no association between semaglutide use and an increased risk of thyroid cancer [1]